PP
PDT Partners Portfolio holdings
AUM
$1.77B
1-Year Return
43.53%
This Quarter Return
-3.6%
1 Year Return
+43.53%
3 Year Return
+141.92%
5 Year Return
+251.03%
10 Year Return
+895.15%
AUM
$1.41B
AUM Growth
+$279M
(+25%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
23.01%
Top 10 Holdings %
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151
Top Buys
| 1 |
HEICO
HEI
|
$6.06M |
| 2 |
Moderna
MRNA
|
$6.02M |
| 3 |
Carvana
CVNA
|
$5.62M |
| 4 |
Axsome Therapeutics
AXSM
|
$5.48M |
| 5 |
Humana
HUM
|
$5.4M |
Top Sells
| 1 |
Ford
F
|
$6.21M |
| 2 |
Robinhood
HOOD
|
$6.06M |
| 3 |
Biogen
BIIB
|
$6.03M |
| 4 |
Akero Therapeutics
AKRO
|
$4.95M |
| 5 |
Comstock Resources
CRK
|
$4.64M |
Sector Composition
| 1 | Technology | 23.57% |
| 2 | Healthcare | 19.71% |
| 3 | Consumer Discretionary | 12.99% |
| 4 | Industrials | 11.32% |
| 5 | Financials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
ACM Research
ACMR
$1.74B
| $2.84M | 0.2% |
121,602
+13,572
| +13% | +$317K |
|
177
Fluence Energy
FLNC
$971M
| $2.84M | 0.2% |
585,084
+558,967
| +2,140% | +$2.71M |
|
178
Keros Therapeutics
KROS
$641M
| $2.81M | 0.2% |
+276,060
| New | +$2.81M |
|
179
Warby Parker
WRBY
$3.12B
| $2.81M | 0.2% |
154,036
+110,789
| +256% | +$2.02M |
|
180
dLocal
DLO
$3.8B
| $2.8M | 0.2% |
336,191
-19,394
| -5% | -$162K |
|
181
Paymentus
PAY
$4.54B
| $2.77M | 0.2% |
106,265
+42,888
| +68% | +$1.12M |
|
182
Reddit
RDDT
$43.8B
| $2.77M | 0.2% |
26,404
+3,304
| +14% | +$347K |
|
183
LiveRamp
RAMP
$1.87B
| $2.73M | 0.19% |
104,500
+10,740
| +11% | +$281K |
|
184
Archrock
AROC
$4.43B
| $2.68M | 0.19% |
102,050
-54,764
| -35% | -$1.44M |
|
185
ResMed
RMD
$40.4B
| $2.65M | 0.19% |
11,835
+300
| +3% | +$67.2K |
|
186
Xometry
XMTR
$2.51B
| $2.65M | 0.19% |
+106,241
| New | +$2.65M |
|
187
AvidXchange
AVDX
$2.06B
| $2.63M | 0.19% |
309,693
| – | – |
|
188
Incyte
INCY
$16.8B
| $2.61M | 0.19% |
43,168
+39,834
| +1,195% | +$2.41M |
|
189
Doximity
DOCS
$12.9B
| $2.59M | 0.18% |
44,564
-1,399
| -3% | -$81.2K |
|
190
Adaptive Biotechnologies
ADPT
$1.94B
| $2.56M | 0.18% |
344,978
+28,697
| +9% | +$213K |
|
191
Parker-Hannifin
PH
$95.4B
| $2.55M | 0.18% |
4,200
| – | – |
|
192
Gilead Sciences
GILD
$143B
| $2.53M | 0.18% |
22,600
+1,496
| +7% | +$168K |
|
193
Aurinia Pharmaceuticals
AUPH
$1.65B
| $2.53M | 0.18% |
314,519
+12,966
| +4% | +$104K |
|
194
DuPont de Nemours
DD
$32.6B
| $2.53M | 0.18% |
+33,817
| New | +$2.53M |
|
195
GE Aerospace
GE
$293B
| $2.52M | 0.18% |
+12,603
| New | +$2.52M |
|
196
Chefs' Warehouse
CHEF
$2.62B
| $2.52M | 0.18% |
46,295
+3,622
| +8% | +$197K |
|
197
Crown Holdings
CCK
$10.9B
| $2.51M | 0.18% |
28,140
-2,773
| -9% | -$248K |
|
198
LegalZoom.com
LZ
$1.93B
| $2.51M | 0.18% |
291,045
-407
| -0.1% | -$3.5K |
|
|
TLN
199
Talen Energy Corporation Common Stock
TLN
$17.1B
| $2.49M | 0.18% |
+12,494
| New | +$2.49M |
|
200
Manulife Financial
MFC
$52B
| $2.47M | 0.18% |
+79,346
| New | +$2.47M |
|